High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$75.5M
$75,509,750
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Daniell Richard
• Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -16.8%
2026-03-05
$547,705
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -16.8%
|
2026-03-05 | $547,705 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Fox Christine
• Officer • EVP, U.S. Commercial
Sell to Cover
2026-03-05
$250,940
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • EVP, U.S. Commercial
Sell to Cover
|
2026-03-05 | $250,940 | S | Form 4 |
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
CEO
Sell to Cover
|
2026-03-05 | $634,160 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Hughes Eric A
• Officer • See "Remarks"
Sell to Cover
2026-03-05
$301,895
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • See "Remarks"
Sell to Cover
|
2026-03-05 | $301,895 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Jover Placid
• Officer • See "Remarks"
10b5-1 SellΔOwn -67.6%
2026-03-05
$448,108
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • See "Remarks"
10b5-1 SellΔOwn -67.6%
|
2026-03-05 | $448,108 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Savage Brian
• Officer • Interim Chief Legal Officer
Sell to Cover
2026-03-05
$35,690
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • Interim Chief Legal Officer
Sell to Cover
|
2026-03-05 | $35,690 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Shields Matthew
• Officer • EVP, Global Operations
10b5-1 SellΔOwn -63.4%
2026-03-05
$547,705
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • EVP, Global Operations
10b5-1 SellΔOwn -63.4%
|
2026-03-05 | $547,705 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Daniell Richard
• Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -14.2%
2026-03-04
$2,983,517Largex3
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -14.2%
|
2026-03-04 | $2,983,517Largex3 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Fox Christine
• Officer • EVP, U.S. Commercial
Sell to CoverΔOwn -10.8%
2026-03-04
$295,362
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • EVP, U.S. Commercial
Sell to CoverΔOwn -10.8%
|
2026-03-04 | $295,362 | S | Form 4 |
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
CEO
Sell to Cover
|
2026-03-04 | $759,442 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Hughes Eric A
• Officer • See "Remarks"
Sell to CoverΔOwn -10.4%
2026-03-04
$366,102
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • See "Remarks"
Sell to CoverΔOwn -10.4%
|
2026-03-04 | $366,102 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Savage Brian
• Officer • Interim Chief Legal Officer
Sell to CoverΔOwn -12.3%
2026-03-04
$86,843x2
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • Interim Chief Legal Officer
Sell to CoverΔOwn -12.3%
|
2026-03-04 | $86,843x2 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Daniell Richard
• Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -35.1%
2026-03-03
$4,173,942Largex2
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • EVP, Europe Commercial
10b5-1 SellΔOwn -35.1%
|
2026-03-03 | $4,173,942Largex2 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Francis Richard D
• CEO
Sell to Cover
2026-03-03
$14,333,332MEGAx2
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
CEO
Sell to Cover
|
2026-03-03 | $14,333,332MEGAx2 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Hughes Eric A
• Officer • See "Remarks"
Sell to CoverΔOwn -44.5%
2026-03-03
$2,613,450Largex2
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • See "Remarks"
Sell to CoverΔOwn -44.5%
|
2026-03-03 | $2,613,450Largex2 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Savage Brian
• Officer • Interim Chief Legal Officer
Sell to CoverΔOwn -30.3%
2026-03-03
$41,227
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • Interim Chief Legal Officer
Sell to CoverΔOwn -30.3%
|
2026-03-03 | $41,227 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Kalif Eliyahu Sharon
• CFO
10b5-1 SellΔOwn -85.8%
2026-02-26
$11,634,708MEGA
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
CFO
10b5-1 SellΔOwn -85.8%
|
2026-02-26 | $11,634,708MEGA | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Francis Richard D
• CEO
10b5-1 SellΔOwn -32.1%
2026-02-15
$15,324,799MEGAx2
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
CEO
10b5-1 SellΔOwn -32.1%
|
2026-02-15 | $15,324,799MEGAx2 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
MIGNONE ROBERTO
• Director
Discretionary SellΔOwn -17.4%
2025-12-16
$2,340,646Large
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Director
Discretionary SellΔOwn -17.4%
|
2025-12-16 | $2,340,646Large | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Weiss Amir
• Officer • Chief Accounting Officer
Discretionary SellΔOwn -68.5%
2025-12-16
$371,504
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • Chief Accounting Officer
Discretionary SellΔOwn -68.5%
|
2025-12-16 | $371,504 | S | Form 4 |
|
TEVA
M
TEVA PHARMACEUTICAL INDUSTRIES LTD
Daniell Richard
• Officer • Exec. VP, European Commercial
Equity Compensation
2025-12-09
$2,124,542Largex4
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • Exec. VP, European Commercial
Equity Compensation
|
2025-12-09 | $2,124,542Largex4 | M | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Daniell Richard
• Officer • Exec. VP, European Commercial
Discretionary SellΔOwn -70.5%
2025-12-09
$3,311,126Large
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • Exec. VP, European Commercial
Discretionary SellΔOwn -70.5%
|
2025-12-09 | $3,311,126Large | S | Form 4 |
|
TEVA
M
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sabag Mark
• Officer • See "Remarks"
Equity Compensation
2025-12-09
$2,209,454Largex2
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • See "Remarks"
Equity Compensation
|
2025-12-09 | $2,209,454Largex2 | M | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sabag Mark
• Officer • See "Remarks"
Discretionary SellΔOwn -44.0%
2025-12-09
$6,230,754Whalex2
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • See "Remarks"
Discretionary SellΔOwn -44.0%
|
2025-12-09 | $6,230,754Whalex2 | S | Form 4 |
|
TEVA
M
TEVA PHARMACEUTICAL INDUSTRIES LTD
Lichtenstein Chen
• Director
Equity Compensation
2025-12-02
$0
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Director
Equity Compensation
|
2025-12-02 | $0 | M | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
MIGNONE ROBERTO
• Director
Discretionary SellΔOwn -10.1%
2025-11-26
$1,301,505Large
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Director
Discretionary SellΔOwn -10.1%
|
2025-11-26 | $1,301,505Large | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Fox Christine
• Officer • EVP, Head of U.S. Commercial
Sell to CoverΔOwn -30.7%
2025-11-20
$699,523
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • EVP, Head of U.S. Commercial
Sell to CoverΔOwn -30.7%
|
2025-11-20 | $699,523 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Fox Christine
• Officer • EVP, Head of U.S. Commercial
Discretionary SellΔOwn -51.4%
2025-11-14
$753,321
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • EVP, Head of U.S. Commercial
Discretionary SellΔOwn -51.4%
|
2025-11-14 | $753,321 | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
MIGNONE ROBERTO
• Director
Discretionary SellΔOwn -28.8%
2025-11-06
$4,821,880Large
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Director
Discretionary SellΔOwn -28.8%
|
2025-11-06 | $4,821,880Large | S | Form 4 |
|
TEVA
S
TEVA PHARMACEUTICAL INDUSTRIES LTD
Weiss Amir
• Officer • Chief Accounting Officer
Discretionary SellΔOwn -40.7%
2025-11-06
$300,564
|
||||||
| TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
Officer • Chief Accounting Officer
Discretionary SellΔOwn -40.7%
|
2025-11-06 | $300,564 | S | Form 4 |